Clinic of Pediatrics, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Santariskiu Str. 4, Vilnius, Lithuania.
Department of Pediatrics, Center for Rare Diseases and Center for Molecular Medicine, University Hospital Cologne and Medical Faculty, University of Cologne, Kerpener Str. 62, Cologne, Germany.
BMC Nephrol. 2023 Apr 4;24(1):86. doi: 10.1186/s12882-023-03140-2.
Autosomal recessive polycystic kidney disease (ARPKD) is a significant cause of morbidity and mortality in infants and children. In severe cases bilateral nephrectomies are considered but may be associated with significant neurological complications and life-threatening hypotension.
We describe a case of a 17 months old boy with genetically confirmed ARPKD who underwent sequential bilateral nephrectomies at the age of 4 and 10 months. Following the second nephrectomy the boy was started on continuous cycling peritoneal dialysis with blood pressure on the lower range. At the age of 12 months after a few days of poor feeding at home the boy experienced a severe episode of hypotension and coma of Glasgow Come Scale of three. Brain magnetic-resonance imaging (MRI) showed signs of hemorrhage, cytotoxic cerebral edema and diffuse cerebral atrophy. During the subsequent 72 h he developed seizures requiring anti-epileptic drug therapy, gradually regained consciousness but remained significantly hypotensive after discontinuation of vasopressors. Thus, he received high doses of sodium chloride orally and intraperitoneally as well as midodrine hydrochloride. His ultrafiltration (UF) was targeted to keep him in mild-to-moderate fluid overload. After two months of stable condition the patient started to develop hypertension requiring four antihypertensive medications. After optimizing peritoneal dialysis to avoid fluid overload and discontinuation of sodium chloride the antihypertensives were discontinued, but hyponatremia with hypotensive episodes reoccurred. Sodium chloride was reintroduced resulting in recurrent salt-dependent hypertension.
Our case report illustrates an unusual course of blood pressure changes following bilateral nephrectomies in an infant with ARPKD and the particular importance of tight regulation of sodium chloride supplementation. The case adds to the scarce literature about clinical sequences of bilateral nephrectomies in infants, and as well highlights the challenge of managing blood pressure in these patients. Further research on the mechanisms and management of blood pressure control is clearly needed.
常染色体隐性多囊肾病(ARPKD)是婴儿和儿童发病和死亡的重要原因。在严重的情况下,会考虑进行双侧肾切除术,但这可能与严重的神经并发症和危及生命的低血压有关。
我们描述了一例 17 个月大的男孩,经基因证实患有 ARPKD,他在 4 个月和 10 个月大时接受了双侧肾切除术。在第二次肾切除术后,男孩开始接受连续循环腹膜透析,血压处于较低范围。在 12 个月大时,在家中几天进食不良后,男孩出现严重低血压和昏迷格拉斯哥昏迷量表评分为 3 分。脑磁共振成像(MRI)显示有出血、细胞毒性脑水肿和弥漫性脑萎缩的迹象。在随后的 72 小时内,他出现癫痫发作,需要抗癫痫药物治疗,逐渐恢复意识,但在停止血管加压素后仍明显低血压。因此,他接受了高剂量的口服和腹腔内氯化钠以及米多君盐酸盐治疗。他的超滤(UF)被设定为保持他处于轻度到中度液体超负荷状态。在稳定了两个月后,患者开始出现高血压,需要四种降压药物。在优化腹膜透析以避免液体超负荷和停止氯化钠后,降压药物被停用,但低钠血症和低血压发作再次出现。重新引入氯化钠导致复发性盐依赖性高血压。
我们的病例报告说明了一例 ARPKD 婴儿双侧肾切除术后血压变化的不寻常过程,以及严格调节氯化钠补充的特别重要性。该病例增加了关于婴儿双侧肾切除术临床序列的罕见文献,并强调了管理这些患者血压的挑战。显然需要进一步研究血压控制的机制和管理。